- Following through on its plan to deleverage after the Shire merger, Takeda Pharmaceutical Company (NYSE:TAK +3.6%) has agreed to sell a portfolio of over-the-counter (OTC) and prescription pharmaceutical products sold in Russia, Georgia and certain CIS countries to STADA Arzneimittel AG for $660M. The transaction should close this quarter.
- The deal is the company's fourth in the last six months as its advances toward its goal of divesting ~$10B in non-core assets.
Takeda to sell portfolio of assets to Stada for $660M; shares up 4%
Recommended For You
About TAK Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
TAK | - | - |
Takeda Pharmaceutical Company Limited |